Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Neurorehabilitation Devices Market: Stroke Recovery Demand, Robotic and Exoskeleton Adoption, and BCI-Enabled Home Rehabilitation Growth to Drive Exceptional Market Expansion Through 2035

The global Neurorehabilitation Devices Market was valued at USD 2.7 billion in 2025 and is forecast to expand at an exceptional CAGR of 15.1%, reaching approximately USD 9.6 billion by 2035. This trajectory is underpinned by rising demand for stroke and spinal cord injury rehabilitation, growing clinical and home use of robotic exoskeletons and gait training systems, and the emergence of brain-computer interface and non-invasive stimulation therapies that extend recovery beyond the early post-injury window. The category comprises neurorobotics, BCI systems, wearable devices, non-invasive neurostimulation, functional electrical stimulation, and virtual and augmented reality rehabilitation systems.

The market’s exceptional 15.1% CAGR reflects the transition of neurorehabilitation from labor-intensive, therapist-dependent care toward technology-assisted, data-driven, and increasingly home-based recovery programs, generating demand from hospitals, rehabilitation centers, and physiotherapy providers that exceeds typical growth rates observed across the wider medical device sector. Sustained procurement of robotic gait and limb rehabilitation systems continues to anchor revenue, while personal exoskeletons, BCI-enabled therapy, and wearable stimulation represent distinct and fast-growing demand channels. Coverage extending across multiple technologies, therapy areas, and care settings underscores the breadth of clinical and engineering infrastructure now supporting this category.

Executive Snapshot

How does stroke recovery demand drive neurorehabilitation devices market growth?
Rehabilitation hospitals and outpatient programs are increasingly using robotic limb and gait systems, functional electrical stimulation, and BCI-enabled devices to restore upper- and lower-limb function in stroke survivors, establishing stroke as the largest single therapy area by device demand. As survival rates improve and evidence shows that meaningful gains are possible even in the chronic phase, procurement associated with stroke rehabilitation is expected to outpace growth across the wider medical device sector.

What role does spinal cord injury rehabilitation play in market growth?
Spinal cord injury centers are adopting personal and clinical exoskeletons alongside non-invasive spinal cord stimulation to support standing, walking, and upper-extremity function. Expanding reimbursement pathways, veterans’ health programs, and channel partnerships with patient care organizations continue to support consistent demand growth within this therapy area.

How does robotic and exoskeleton adoption sustain neurorehabilitation devices market growth?
Providers value robotic systems for their ability to deliver high-intensity, repetitive, and measurable therapy while reducing physical strain on clinical staff. Growing installed bases in hospitals and the shift of wearable exoskeletons into community and home use are generating demand that exceeds levels attributable to conventional therapy equipment alone.

What is driving demand for BCI-enabled and non-invasive stimulation rehabilitation?
Randomized clinical evidence for at-home BCI therapy and continued interest in transcranial and transcutaneous stimulation are extending neurorehabilitation to chronic patients previously considered to have plateaued. This broadening of eligible patients is generating incremental demand among neurologists and rehabilitation specialists.

How does home-based and virtual rehabilitation sustain the neurorehabilitation devices market?
Therapist shortages, rising post-acute care costs, and patient preference for home recovery continue to drive investment in wearable devices, remote monitoring, and virtual and augmented reality therapy platforms. As payers and providers adopt remote care models, home-based rehabilitation is emerging as a growth driver of comparable significance to facility-based robotics.

Which neurorehabilitation devices market segments are growing fastest?
The fastest-growing segments include BCI systems for stroke rehabilitation, wearable exoskeletons and smart sensors, non-invasive spinal cord and transcranial stimulation, virtual and augmented reality rehabilitation systems, and home-care settings supported by connected and remotely supervised therapy.

Request Sample
Speak with an Analyst
Download TOC

Market Dynamics: Neurorehabilitation Devices Market

  • Neurorobotics sustaining the leading share of neurorehabilitation revenue: Robotic exoskeletons, limb rehabilitation, and gait training systems continue to represent the largest product category by procurement value.
  • Stroke and spinal cord injury sustaining the core demand base: These two therapy areas continue to account for the majority of device utilization across rehabilitation hospitals and specialized centers.
  • BCI and non-invasive stimulation sustaining demand growth above conventional therapy equipment: New clinical evidence and commercial availability continue to direct incremental investment toward neural-signal-driven rehabilitation.
  • Parkinson’s disease, multiple sclerosis, and traumatic brain injury sustaining a broadening addressable base: Balance, gait, and cognitive rehabilitation technologies continue to extend device use beyond stroke and spinal cord injury.
  • Home-care and wearable devices sustaining a shift in care delivery: Personal exoskeletons, wearable stimulation, and remote therapy platforms continue to move rehabilitation from facilities into daily life.
  • Hospitals and rehabilitation centers sustaining primary care delivery: Facilities equipped with robotic and advanced therapy systems continue to serve as the principal point of care and the main training ground for home use.

Market Segmentation: Neurorehabilitation Devices Market

By Product
  • Neurorobotics
    • Robotic Exoskeletons
    • Robotic Limb Rehabilitation Systems
    • Robotic Gait Training Systems
    • Other Neurorobotic Systems
  • Brain-Computer Interface (BCI) Systems
    • Invasive BCI
    • Semi-invasive BCI
    • Non-invasive BCI
  • Wearable Neurorehabilitation Devices
    • Wearable Exoskeletons
    • Smart Wearable Sensors
    • Wearable Electrical Stimulation Devices
    • Other Wearable Devices
  • Non-invasive Neurostimulation Devices
    • Transcranial Magnetic Stimulation (TMS)
    • Transcranial Direct Current Stimulation (tDCS)
    • Other Non-invasive Stimulation Devices
  • Functional Electrical Stimulation (FES) Devices
  • Virtual Reality & Augmented Reality Rehabilitation Systems
  • Other Neurorehabilitation Devices
By Therapy Area
  • Stroke
  • Parkinson’s Disease
  • Multiple Sclerosis
  • Spinal Cord Injury
  • Traumatic Brain Injury
  • Cerebral Palsy
  • Multiple System Atrophy & Other Movement Disorders
  • Peripheral Neuropathy
  • Other Neurological Disorders
By Rehabilitation Function
  • Motor Rehabilitation
    • Upper-Limb Rehabilitation
    • Lower-Limb Rehabilitation
    • Gait Rehabilitation
  • Cognitive Rehabilitation
  • Speech & Language Rehabilitation
  • Balance & Coordination Rehabilitation
  • Sensory Rehabilitation
  • Other Rehabilitation Functions
By End User
  • Hospitals
  • Rehabilitation Centers
  • Specialty Clinics
  • Physiotherapy Centers
  • Ambulatory Care Centers
  • Home-care Settings
  • Research & Academic Institutes
  • Other End Users
By Patient Age
  • Pediatric
  • Adult
  • Geriatric
By Geography
  • North America: United States, Canada, and Mexico
  • Europe:  Germany, U.K., France, Italy, Spain, Russia, Benelux, Nordics, and Rest of Europe
  • Asia Pacific: China, Japan, India, South Korea, Australia, New Zealand, Taiwan, South East Asia, and Rest of Asia Pacific
  • Latin America: Brazil, Argentina, Columbia, Chile, Peru, and Rest of Latin America
  • Middle East: Saudi Arabia, United Arab Emirates, Oman, Qatar, and Rest of Middle East
  • Africa: Nigeria, Egypt, Ethiopia, South Africa, and Rest of Africa

Key Growth Drivers: Neurorehabilitation Devices Market

  1. Rising stroke survivorship and aging populations supporting continued rehabilitation demand: Growing numbers of people living with the long-term effects of stroke and other neurological conditions continue to support device procurement that exceeds the wider medical device baseline.
  2. Therapist shortages and cost pressures accelerating technology-assisted therapy: Robotic and automated systems that increase therapy intensity per clinician hour continue to gain priority among rehabilitation providers.
  3. Maturing clinical evidence for BCI and neuromodulation-based rehabilitation reshaping competitive positioning: Randomized and real-world data continue to validate neural-signal-driven and stimulation-based therapies for chronic patients.
  4. Expanding reimbursement and distribution channels broadening patient access: Medicare pathways for personal exoskeletons, veterans’ programs, and partnerships with orthotics and prosthetics providers continue to extend device reach.
  5. Growth of home-based, wearable, and virtual rehabilitation expanding the addressable market: Connected devices and remote supervision continue to enable therapy outside the clinic and extend treatment duration.
  6. Advances in sensors, AI, and gamified VR/AR supporting engagement and measurable outcomes: Data-rich platforms continue to personalize therapy and provide objective progress tracking for clinicians and payers.

Regional Outlook: Neurorehabilitation Devices Market

  • North America: The United States accounts for the largest share of regional demand, supported by high stroke and spinal cord injury rehabilitation volumes, Medicare and Veterans Affairs coverage for selected devices, and a dense network of inpatient rehabilitation facilities; regional providers continue to expand robotic and home-based therapy capacity to accommodate this demand.
  • Europe: Germany, Switzerland, France, the Netherlands, and the United Kingdom anchor regional demand, supported by long-standing adoption of rehabilitation robotics, structured post-acute care pathways, and strong clinical research networks; this demand base is expected to remain broadly stable through the forecast period.
  • Asia-Pacific: Japan, China, South Korea, and Australia represent some of the fastest-growing regional markets as rapidly aging populations and rising stroke incidence drive investment in robotic rehabilitation and wearable devices; regional governments and hospital systems continue to build the infrastructure required to support this expansion.
  • Latin America: Brazil and Mexico represent an emerging regional demand base as specialized rehabilitation centers begin to adopt robotic and stimulation-based therapies; this segment is expected to follow a steady, if more gradual, growth trajectory through 2035.

Competitive Landscape: Neurorehabilitation Devices Market

Key Players
Ekso Bionics Holdings, Inc., Lifeward Ltd., CYBERDYNE Inc., DIH Holding US, Inc. (Hocoma), Bionik Laboratories Corp., Tyromotion GmbH, Myomo, Inc., ONWARD Medical N.V., Kandu, Inc. (Neurolutions), MicroTransponder, Inc., MindMaze SA, Motus Nova, Fourier Intelligence, Barrett Medical, Wandercraft SAS, Bioventus Inc. (Bioness), HASOMED GmbH, Saebo, Inc., Harmonic Bionics, Inc., NEOFECT, XRHealth, BrainsWay Ltd., The Magstim Company Limited

  • ONWARD Medical N.V. [September 2026] — reported first-half 2026 results showing strong commercial traction for its non-invasive ARC-EX spinal cord stimulation system, now available in more than 130 U.S. clinics including expanded home-use access through the Veterans Affairs healthcare system, alongside progress in its ARC-IM pivotal and feasibility studies.
  • Lifeward Ltd. [August 2026] — launched a six-month pilot program with Ottobock Care to broaden U.S. access to the ReWalk 7 Personal Exoskeleton for people with spinal cord injury, leveraging Ottobock Care’s nationwide network of patient care clinics for evaluation, training, and follow-up.
  • Kandu, Inc. (Neurolutions) [February 2026] — announced results from the first randomized controlled trial of an FDA-cleared, non-invasive brain-computer interface therapy in chronic stroke, presented at the International Stroke Conference 2026, showing that at-home IpsiHand users achieved significantly greater upper-extremity motor improvement than a home exercise program.

Consultant POV

The Neurorehabilitation Devices Market’s exceptional 15.1% CAGR, projected to take the market from USD 2.7 billion in 2025 to approximately USD 9.6 billion by 2035, is anchored in sustained stroke and spinal cord injury rehabilitation demand, growing adoption of robotic and exoskeleton systems, and the expansion of BCI-enabled and home-based therapy. Sustained clinical and commercial activity from companies including ONWARD Medical N.V., Lifeward Ltd., and Kandu, Inc. (Neurolutions) confirms the Neurorehabilitation Devices Market will sustain exceptional growth through 2035.

Request Sample
Speak with an Analyst
Download TOC

About Constancy Researchers Private Limited

Constancy Researchers is a global market intelligence and strategic advisory firm helping organizations navigate complex markets and make high-impact decisions with confidence. In an environment defined by rapid technological change, shifting demand patterns, and evolving competitive dynamics, we provide clarity where it matters most—at the point of decision-making. By combining deep industry understanding, rigorous analytics, and structured thinking, we enable leadership teams to identify opportunities, mitigate risks, and build strategies that drive sustainable growth.

More Press Releases

Speak with an Analyst

    Download TOC

      Request a Sample Report